Established as a partnership in global health, the Global Fund works closely with a wide diversity of partners –implementing governments, donors, civil society, international development organizations, the private sector and communities living with and affected by the diseases. This partnership model actively supports country-owned approaches that develop and implement effective, evidence-based programs to respond to AIDS, tuberculosis and malaria.
24 March 2010
Further significant declines in TB prevalence and mortality can be achieved if we go on scaling up interventions at the pace set in recent years. We can also contain the growing threat of multidrug-resistant TB. Decisions that leaders make in 2010 will be critical for building on gains we have already made.
“On the move against tuberculosis, innovate to accelerate action,” this year’s theme for world TB day, is highly relevant.
This year is a particularly important one for tuberculosis – marking the final stretch in the road to achieving the Millennium Development Goals by 2015. Despite considerable investments and progress by the Global Fund to Fight Aids, Tuberculosis and Malaria and all the partners and other financial and technical organizations, we must find innovative ways to detect and treat all TB cases and to scale up the management of MDR cases.
Through 2009, programs funded by the Global Fund have provided treatment to 6 million people with active TB. The Global Fund has provided nearly two-thirds of the external financing for TB and multidrug-resistant TB (MDR-TB) control efforts in low- and middle income countries. Approved TB proposals total close to US$ 3.2 billion covering 112 countries, contributing nearly half of the projected coverage required to achieve Stop TB Partnership targets for the detection and treatment of new smear-positive TB cases. TB programs supported by the Global Fund have also provided 1.8 million TB/HIV services. In many countries in which the Global Fund supports programs, TB prevalence is falling, as are TB mortality rates.
Such unprecedented progress would not have been possible without the support of donors and partner organizations.
“2010 will be decisive. Decisions that leaders will make this year will be critical for sustaining the gains achieved. If we continue to scale up interventions at the pace set in recent years, we could achieve further significant declines in TB prevalence and mortality, and we could contain the threat of multidrug-resistant TB.”
Dr Michel KazatchkineExecutive DirectorThe Global Fund to Fight AIDS, Tuberculosis and Malaria
Stop TB PartnershipWorld TB Day Website
Contact | Report Fraud and Abuse | Legal | RSS | Sitemap
© 2014 The Global Fund to Fight AIDS, Tuberculosis and Malaria